Kalytera terminates preclinical programs for synthetic endocannabinoid compounds in bone disease April 17, 2018
Aeglea reports phase I/II data on pegzilarginase in patients with arginase 1 deficiency April 16, 2018
Novel LDLR-PCSK9 protein-protein interaction inhibitors discovered at Texas A&M University April 12, 2018
FDA requires extended time to review additional information regarding NDA for elagolix April 11, 2018
RSS